Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up
- PMID: 38526503
- PMCID: PMC11254237
- DOI: 10.1097/JS9.0000000000001369
Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up
Abstract
Background: Although the beneficial properties of vitamin D in anti-inflammation and immunity-modulation are promising in the management of inflammatory bowel disease (IBD), data were limited for the critical IBD prognosis. The association between serum vitamin D levels and the risk of bowel resection in individuals with IBD remains largely unknown.
Materials and methods: The authors performed a longitudinal cohort study among 5474 individuals with IBD in the UK Biobank. Serum 25-hydroxyvitamin D [25(OH)D] was measured using direct competitive chemiluminescent immunoassay. Bowel resection events were ascertained via national inpatient data. Multivariable-adjusted Cox proportional hazard regression was used to examine the association between serum 25(OH)D and bowel resection risk, presented with hazard ratios (HRs) and 95% CIs. Restricted cubic spline (RCS) was used to evaluate dose-response associations.
Results: During a mean follow-up of 13.1 years, the authors documented 513 incident bowel resection cases. Compared to participants with vitamin D deficiency, nondeficient participants showed a significantly reduced bowel resection risk in IBD (HR 0.72, 95% CI: 0.59-0.87, P =0.001), Crohn's disease (CD, HR 0.74, 95% CI: 0.56-0.98, P =0.038), and ulcerative colitis (UC, HR 0.73, 95% CI: 0.57-0.95, P =0.020). When comparing extreme quintiles of 25(OH)D level, participants with IBD showed a 34% reduced risk of bowel resection (95% CI: 11-51%, P =0.007) and participants with UC showed a 46% reduced risk (95% CI: 19-64%, P =0.003), while this association was not significant in CD (HR 0.93, 95% CI: 0.59-1.45, P =0.740). Linear dose-response associations were observed using the RCS curve (all P -nonlinearity>0.05).
Conclusion: Increased serum level of 25(OH)D is independently associated with reduced bowel resection risk in IBD. This association was significant in UC but may not be stable in CD. Vitamin D deficiency is a risk factor for bowel resection in individuals with IBD, and may be an effective metric in predicting and risk-screening surgical events.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Figures



Similar articles
-
Nonlinear Association between Serum 25-Hydroxyvitamin D and All-Cause Mortality in Adults with Inflammatory Bowel Disease in a Prospective Cohort Study.J Nutr. 2022 Sep 6;152(9):2125-2134. doi: 10.1093/jn/nxac148. J Nutr. 2022. PMID: 35816464
-
Vitamin D and Inflammatory Bowel Disease: Mendelian Randomization Analyses in the Copenhagen Studies and UK Biobank.J Clin Endocrinol Metab. 2018 Sep 1;103(9):3267-3277. doi: 10.1210/jc.2018-00250. J Clin Endocrinol Metab. 2018. PMID: 29947775
-
Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases.JPEN J Parenter Enteral Nutr. 2014 Mar-Apr;38(3):385-91. doi: 10.1177/0148607113504002. Epub 2013 Oct 2. JPEN J Parenter Enteral Nutr. 2014. PMID: 24088707
-
Review article: vitamin D and inflammatory bowel diseases.Aliment Pharmacol Ther. 2014 Jan;39(2):125-36. doi: 10.1111/apt.12553. Epub 2013 Nov 17. Aliment Pharmacol Ther. 2014. PMID: 24236989 Free PMC article. Review.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
-
Higher Life's Essential 8 score is associated with reduced risk of related surgery and all-cause mortality among 3232 individuals with inflammatory bowel disease in a longitudinal cohort study.Int J Surg. 2025 May 1;111(5):3248-3255. doi: 10.1097/JS9.0000000000002335. Int J Surg. 2025. PMID: 40072359 Free PMC article.
-
Innate Lymphoid Cells in Inflammatory Bowel Disease.Cells. 2025 Jun 2;14(11):825. doi: 10.3390/cells14110825. Cells. 2025. PMID: 40498001 Free PMC article. Review.
-
A commentary on 'Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up'.Int J Surg. 2024 Aug 1;110(8):5220-5221. doi: 10.1097/JS9.0000000000001506. Int J Surg. 2024. PMID: 38701501 Free PMC article. No abstract available.
-
A commentary on 'Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up'.Int J Surg. 2024 Aug 1;110(8):5194-5195. doi: 10.1097/JS9.0000000000001494. Int J Surg. 2024. PMID: 38640509 Free PMC article. No abstract available.
References
-
- Le Berre C, Peyrin-Biroulet L. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology 2021;160:1452–1460.e21. - PubMed
-
- Frolkis AD, Dykeman J, Negrón ME, et al. . Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013;145:996–1006. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical